Markku Taskinen

Predicting the Formation and Stability of Amorphous Small Molecule Binary Mixtures from Computationally Determined Flory−Huggins Interaction Parameter and Phase Diagram

Katja Pajula, Markku Taskinen, Vesa‐Pekka Lehto et al. · Molecular Pharmaceutics · 2010 · 176 citations

Natural Sciences, Chemistry, Computational Chemistry +16

Growth Inhibition of Macrophage-Like and Other Cell Types by Liposome-Encapsulated, Calcium-Bound, and Free Bisphosphonates<i>In Vitro</i>

Jukka Mönkkönen, Markku Taskinen, Seppo Auriola et al. · Journal of drug targeting · 1994 · 96 citations

Medicine, Cell Biology, Pharmacology +17

Studies on liposome formulations for intra-articular delivery of clodronate

Jukka Mönkkönen, Jaana Liukkonen, Markku Taskinen et al. · Journal of Controlled Release · 1995 · 39 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Inhibition of mevalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cytokine secretion from macrophages in vitro

Anu Töyräs, Jouko Ollikainen, Markku Taskinen et al. · European Journal of Pharmaceutical Sciences · 2003 · 37 citations

Life Sciences, Immunology, Pharmacology +8

Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells

Johanna Räikkönen, Markku Taskinen, James E. Dunford et al. · Biochemical and Biophysical Research Communications · 2011 · 18 citations

Life Sciences, Biochemistry, Pharmacology +14